Lipids changes in liver cancer.
- Author:
Jing-Ting JIANG
1
;
Ning XU
;
Xiao-Ying ZHANG
;
Chang-Ping WU
Author Information
1. Department of Tumor Biological Treatment, the Third Affiliated Hospital, Suzhou University, Changzhou, China. jjtnew@163.com
- Publication Type:Journal Article
- MeSH:
Animals;
Apolipoproteins;
metabolism;
Cholesterol;
metabolism;
Fatty Acids;
metabolism;
Humans;
Lipid Metabolism;
Lipoprotein(a);
metabolism;
Lipoproteins, HDL;
metabolism;
Lipoproteins, LDL;
metabolism;
Liver Neoplasms;
metabolism;
Triglycerides;
metabolism
- From:
Journal of Zhejiang University. Science. B
2007;8(6):398-409
- CountryChina
- Language:English
-
Abstract:
Liver is one of the most important organs in energy metabolism. Most plasma apolipoproteins and endogenous lipids and lipoproteins are synthesized in the liver. It depends on the integrity of liver cellular function, which ensures homeostasis of lipid and lipoprotein metabolism. When liver cancer occurs, these processes are impaired and the plasma lipid and lipoprotein patterns may be changed. Liver cancer is the fifth common malignant tumor worldwide, and is closely related to the infections of hepatitis B virus (HBV) and hepatitis C virus (HCV). HBV and HCV infections are quite common in China and other Southeast Asian countries. In addition, liver cancer is often followed by a procession of chronic hepatitis or cirrhosis, so that hepatic function is damaged obviously on these bases, which may significantly influence lipid and lipoprotein metabolism in vivo. In this review we summarize the clinical significance of lipid and lipoprotein metabolism under liver cancer.
